title: Bevacizumab is active as a single agent against recurrent malignant gliomas.
authors.affiliation: The University of Alabama at Birmingham, Department of Neurology, Birmingham, AL, USA.
authors.forename: Caroline A
authors.initials: CA
authors.lastname: Agha
authors.forename: Saman
authors.initials: S
authors.lastname: Ibrahim
authors.forename: Ahmed
authors.initials: A
authors.lastname: Hassan
authors.forename: Dean A
authors.initials: DA
authors.lastname: Elias
authors.forename: Hassan M
authors.initials: HM
authors.lastname: Fathallah-Shaykh